Morning Market Losers

dipped 23.23 percent to $31.60 on Q3 results. AMAG Pharmaceuticals reported Q3 earnings of $1.02 per share on revenue of $103.5 million.

shares dropped 22.13 percent to $5.56 after the company reported downbeat Q3 results.

shares declined 15.71 percent to $2.36 on Q3 results. MeetMe reported a Q3 loss of $0.04 per share on revenue of $14.3 million.

shares fell 10.84 percent to $46.63 after the company reported weaker-than-expected earnings for the third quarter and issued a weak FY15 forecast.

slipped 10.14 percent to $13.29 after the company reported the pricing of secondary public offering by GA Holdings LLC.

shares declined 8.54 percent to $21.84 after the company reported downbeat Q3 earnings.

slipped 7.74 percent to $35.06. Cognex issued a weak revenue outlook and announced a new $100 million buyback program.

fell 7.75 percent to $33.11. Qualys reported upbeat Q3 earnings, but the company issued a weak sales forecast.

dropped 7.71 percent to $42.71 after the company reported weaker-than-expected results for the third quarter.

shares dipped 7.03 percent to $15.21 after the company reported results from Phase 2 KINSHIP trial with AQX-1125.

shares slipped 6.74 percent to $38.05. Fitbit reported stronger-than-expected results for the third quarter and also announced a follow-on public offering of its common stock.